The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma

Cancer

Volumn 85, Issue 4, 1999, Pages 769-778

  Glickman, Jonathan N ^a   Torres, Carlos ^a   Wang, Helen H ^b   Turner, Jerrold R ^a   Shahsafaei, Aliakbar ^a   Richards, William G ^a   Sugarbaker, David J ^a   Odze, Robert D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adenocarcinoma; Cytokeratins; Esophageal neoplasms; Immunohistochemistry; Squamous cell carcinoma

Indexed keywords

CYTOKERATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033557603     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990215)85:4<769::AID-CNCR3>3.0.CO;2-I     Document Type: Article

References (33)

1. Streitz JM Jr., Ellis FH Jr., Gibb SP, Balogh K, Watkins E Jr. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg 1991;213:122-5.
2. Paraf F, Flejou JF, Pignon JP, Feliete F, Potet F. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases. Am J Surg Pathol 1995;19:183-91.
3. Yoshida M, Ide H, Yamada A, Endo M. Early detection of adenocarcinoma of the esophagus. Endoscopy 1986;18: 44-8.
4. Liu FS, Wang QL. Squamous cell carcinoma of the esophagus. In: Ming SC, Goldman H, editors. Pathology of the gastrointestinal tract. Philadelphia: W.B. Saunders Company, 1992:439-58.
5. Robery-Cafferty SS, El-Naggar AK, Sahin AA, Bruner JM, Ro JY, Cleary KR. Prognostic factors in esophageal squamous carcinoma. Am J Clin Pathol 1991;95:844-9.
6. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors. International Union Against Cancer. 5th edition. New York: John Wiley & Sons, 1997.
7. Maehara Y, Oshiro T, Endo K, Baba H, Oda S, Ichiyoshi Y, et al. Clinical significance of occult micrometastases in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1995;119:397-402.
8. Ishida K, Katsuyama T, Sugiyama A, Kawasaki S. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer 1997;79:1069-76.
9. Isozaki H, Okajima K, Fujii K. Histological evaluation of lymph node metastasis on serial sectioning in gastric cancer with radical lymphadenectomy. Hepatogastroenterology 1997;44:1133-6.
10. Greenson J, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994;73:563-9.
11. Cutait R, Alves VAF, Lopes LC, Cutait DE, Borges JLA, Singer J, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991;34:917-22.
12. Passlick B, Izbicki JR, Kubuschok B, Nahrath W, Thetter O, Pichlmeier U, et al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small cell lung cancer. J Clin Oncol 1994;12:1827-32.
13. Izbicki JR, Passwick B, Hosch SB, Kubuschock B, Schneider C, Busch C, et al. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastases. J Thorac Cardiovasc Surg 1996;112:623-30.
14. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996;73:88-95.
15. Bussolati G, Gugliotta P, Morra I, Pietribiasi F, Berardengo E. The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Br J Cancer 1988;54:631-6.
16. International Breast Cancer Study Group. Prognostic significance of occult lymph node micrometastases from breast cancers. Lancet 1990;335:1565-8.
17. Noel P, Chauvin F, Michot JP, Catimel G, Hesch M, Groleas M. Prognostic value of lymph node micrometastases detected by immunohistochemistry. Study of 168 cases of breast cancer with a 10 year followup. Ann Pathol 1991;11:309-15.
18. de Mascarel I, Bonichon F, Coindre JM, Tojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 1992;66:523-7.
19. Kainz C, Qitsch G, Lee A, Danihel L, Breitnecker G. Infiltrating lobular breast carcinoma: detection of occult regional lymph node metastasis by immunohistochemistry. Anticancer Res 1993;13:73-4.
20. Tsuchiya A, Sugano K, Kimijima I, Abe R. Immunohistochemical evaluation of lymph node micrometastases from breast cancer. Acta Oncol 1996;35:425-8.
21. Clare SE, Sever SF, Wilkens W, Goldschmidt R, Merkel D, Winchester DJ. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol 1997;4:447-51.
22. Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997; 337:1188-94.
23. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. American Joint Committee on Cancer manual for staging of cancer. 5th edition. Philadelphia: Lippincott-Raven, 1997.
24. Jass JR, Cuzick J, Bussey HJR, Morson BC, Northover JMA, Todd IP. The grading of rectal cancer: historical perspective and a multivariate analysis of 447 cases. Histopathology 1986;10:437-59.
25. Graham DM, Appelman HD. Crohn's like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol 1990;3:332-5.
26. Harrison JC, Dean PJ, El-zeky F, Vander Zwaag R. Impact of Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis. Hum Pathol 1995;26:31-8.
27. Pinkus GS, Etheridge CC, O'Connor EM. Are keratin proteins a better tumor marker tham epithelial membrane antigen? A comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal and polyclonal antibodies. Am J Clin Pathol 1986;85:269-77.
28. Goddard MJ, Wilson B, Grant JW. Comparison of commercially available cytokeratin antibodies in normal and neoplastic adult epithelial and non-epithelial tissues. J Clin Pathol 1991;44:660-3.
29. Gown AM, Boyd HC, Chang Y, Ferguson M, Reichler B, Tippens D. Smooth muscle cells can express cytokeratin of simple epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. Am J Pathol 1988;132:223-32.
30. Domagala W, Bedver E, Chosia M, Weber K, Osborn M. Keratin positive reticulum cells in fine needle aspirates and touch imprints of hyperplastic lymph nodes. Acta Cytol 1991;36:241-5.
31. Weeks DA, Beckwith JB, Mierau GW. Benign nodal lesions mimicking metastases from pediatric renal neoplasms: a report of the National Wilms' Tumor Study Pathology Center. Hum Pathol 1990;21:1239-44.
32. Lewin KJ, Appelman HD, editors. Tumors of the esophagus and stomach. In: Atlas of tumor pathology. 3rd Series. Volume 18. Washington, DC: Armed Forces Institute of Pathology, 1995:43-139.
33. Cascineli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial. Lancet 1998;351:793-6.